Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Sep 24, 2026, 4:00 PM EDT
1.140
+0.010 (0.88%)
After-hours: Sep 24, 2026, 4:47 PM EDT
Alaunos Therapeutics Employees
Alaunos Therapeutics had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$3,000
Profits / Employee
-$4,116,000
Market Cap
2.87M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2023 | 1 | -33 | -97.06% | 1 | 0 |
| Dec 31, 2022 | 34 | -7 | -17.07% | 34 | 0 |
| Dec 31, 2021 | 41 | -65 | -61.32% | 41 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| PMGC Holdings | 34 |
| Aptevo Therapeutics | 33 |
| GeoVax Labs | 19 |
| VivoSim Labs | 15 |
| BioRestorative Therapies | 14 |
| Genprex | 13 |
| Addex Therapeutics | 3 |
TCRT News
- 6 days ago - Alaunos Therapeutics prices 380,469 shares at $1.46 in registered direct offer - TheFly
- 6 days ago - Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules - GlobeNewsWire
- 5 weeks ago - Alaunos Therapeutics Quarterly report: Q2 2026 - Filings
- 4 months ago - Alaunos Therapeutics reports metabolic improvements with ALN1003 in studies - TheFly
- 4 months ago - Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies - GlobeNewsWire
- 4 months ago - Alaunos Therapeutics reports updated preclinical data from ALN1003 mouse studies - TheFly
- 4 months ago - Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models - GlobeNewsWire
- 4 months ago - Alaunos Therapeutics Quarterly report: Q1 2026 - Filings